GT200500282A - Heteroatomos conteniendo compuestos triciclicos. - Google Patents

Heteroatomos conteniendo compuestos triciclicos.

Info

Publication number
GT200500282A
GT200500282A GT200500282A GT200500282A GT200500282A GT 200500282 A GT200500282 A GT 200500282A GT 200500282 A GT200500282 A GT 200500282A GT 200500282 A GT200500282 A GT 200500282A GT 200500282 A GT200500282 A GT 200500282A
Authority
GT
Guatemala
Prior art keywords
heteroatomos
tricycle
compounds
tricycle compounds
epicloro
Prior art date
Application number
GT200500282A
Other languages
English (en)
Inventor
Maximilian Grassberger
Amarylla Horvath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0422643A external-priority patent/GB0422643D0/en
Priority claimed from GB0427599A external-priority patent/GB0427599D0/en
Application filed filed Critical
Publication of GT200500282A publication Critical patent/GT200500282A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS TRICÍCLICOS QUE CONTIENEN ÁTOMOS HETEROGÉNEOS, POR EJEMPLO A UN PROCEDICMIENTO PARA LA PRODUCCIÓN DE 33-EPICLORO-33-DESOXIASCOMICINA O 33-EPI-33-CLORO-FR 520, EL MISMO PUEDE SER UTILIZADO PARA EL TRATAMIENTO DE ENFERMEDADES INMUNES, ALERGICAS, DE LA PIEL COM POR EJEMPLO PSORIASIS, DERMATITIS ATOPICA, ENTRE OTRAS.
GT200500282A 2004-10-12 2005-10-07 Heteroatomos conteniendo compuestos triciclicos. GT200500282A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0422643A GB0422643D0 (en) 2004-10-12 2004-10-12 Organic compounds
GB0427599A GB0427599D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
GT200500282A true GT200500282A (es) 2006-05-04

Family

ID=36084355

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200500282A GT200500282A (es) 2004-10-12 2005-10-07 Heteroatomos conteniendo compuestos triciclicos.

Country Status (28)

Country Link
US (1) US7514554B2 (es)
EP (1) EP1802635B8 (es)
JP (1) JP5032326B2 (es)
KR (1) KR101228188B1 (es)
CN (1) CN101031573B (es)
AR (1) AR051386A1 (es)
AU (1) AU2005293799B2 (es)
BR (1) BRPI0516873A (es)
CA (1) CA2581046C (es)
DK (1) DK1802635T3 (es)
EC (1) ECSP077384A (es)
ES (1) ES2389206T3 (es)
GT (1) GT200500282A (es)
HK (1) HK1105634A1 (es)
IL (1) IL182307A (es)
JO (1) JO2727B1 (es)
MA (1) MA28932B1 (es)
MX (1) MX2007004258A (es)
MY (1) MY140880A (es)
NO (1) NO338603B1 (es)
NZ (1) NZ554010A (es)
PE (1) PE20060581A1 (es)
PL (1) PL1802635T3 (es)
PT (1) PT1802635E (es)
RU (1) RU2394037C2 (es)
TN (1) TNSN07133A1 (es)
TW (1) TWI361192B (es)
WO (1) WO2006040111A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2584360A1 (en) * 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoeruen Mukoedo Reszvenytarsasag Processes for producing crystalline macrolides
IT1394309B1 (it) 2009-05-22 2012-06-06 Poli Ind Chimica Spa Nuovo approccio chimico-enzimatico alla sintesi del pimecrolimus
CN106854228B (zh) * 2015-12-08 2020-05-29 博瑞生物医药（苏州）股份有限公司 一种吡美莫司的制备方法
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
SI3619215T1 (sl) * 2017-05-01 2022-05-31 Meda Pharma Gmbh & Co. Kg Postopek za pretvorbo surovega askomicina v prečiščen pimekrolimus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464366A (en) 1979-12-19 1984-08-07 Ciba Geigy Corporation Cephem compounds having a terminal aminocarboxylic acid grouping and containing an azacyclyl(thio)ureido group
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
DK0427680T3 (da) 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
EP0480623A1 (en) 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
MY110603A (en) 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
US6160117A (en) 1997-11-06 2000-12-12 Zeneca Limited Chemical process
GB0012383D0 (en) 2000-05-22 2000-07-12 Novartis Ag Organic compounds
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines

Also Published As

Publication number Publication date
TW200626603A (en) 2006-08-01
CA2581046A1 (en) 2006-04-20
EP1802635B1 (en) 2012-06-06
JO2727B1 (en) 2013-09-15
WO2006040111A3 (en) 2006-06-22
MA28932B1 (fr) 2007-10-01
EP1802635A2 (en) 2007-07-04
EP1802635B8 (en) 2013-04-17
MY140880A (en) 2010-01-29
CN101031573A (zh) 2007-09-05
NO20072127L (no) 2007-06-08
CA2581046C (en) 2013-03-26
PE20060581A1 (es) 2006-08-17
DK1802635T3 (da) 2012-09-10
WO2006040111A2 (en) 2006-04-20
US20080071082A1 (en) 2008-03-20
JP5032326B2 (ja) 2012-09-26
RU2394037C2 (ru) 2010-07-10
NO338603B1 (no) 2016-09-12
NZ554010A (en) 2009-10-30
JP2008515945A (ja) 2008-05-15
AR051386A1 (es) 2007-01-10
MX2007004258A (es) 2007-05-11
CN101031573B (zh) 2010-06-09
AU2005293799B2 (en) 2009-02-26
ECSP077384A (es) 2007-05-30
HK1105634A1 (en) 2008-02-22
IL182307A0 (en) 2007-09-20
PL1802635T3 (pl) 2013-07-31
BRPI0516873A (pt) 2008-09-23
TWI361192B (en) 2012-04-01
KR101228188B1 (ko) 2013-01-30
RU2007117497A (ru) 2008-11-20
US7514554B2 (en) 2009-04-07
TNSN07133A1 (en) 2008-11-21
AU2005293799A1 (en) 2006-04-20
ES2389206T3 (es) 2012-10-24
PT1802635E (pt) 2012-08-21
IL182307A (en) 2011-06-30
KR20070063535A (ko) 2007-06-19

Similar Documents

Publication Publication Date Title
UY30931A1 (es) Amidas de 4-aril-1,4-dihidro-1,6-naftiridina sustituidas y su uso
AR057239A1 (es) Inmunoglobulinas
GT200900268A (es) Polipeptidos de factor vii modificados y usos de los mismos .
UY30578A1 (es) Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
GT200800184A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
TW200637614A (en) Bendamustine pharmaceutical compositions
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
UY28724A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
UY30414A1 (es) Metano sulfonatos, propano-1-sulfonatos y ciclopropan sulfonatos sustituidos con [2,3,4,8-tetrahidroimidazo-[1,5-al-pirimidin-8-il]-fenilo, composiciones farmacéuticas conteniéndolos y aplicaciones.
GT200600167A (es) Derivados de dihidrobenzofurano y usos de los mismos
CR10336A (es) Compuestos organicos y sus usos
PA8627001A1 (es) Compuestos para el tratamiento de enfermedades
PA8766201A1 (es) Metodos de fabricacion y uso de compuestos y composiciones
ECSP056164A (es) Compuestos utiles para el tratamiento de enfermedades
UY32240A (es) Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
GT200500282A (es) Heteroatomos conteniendo compuestos triciclicos.
DOP2006000087A (es) Compuestos heteroaromaticos acilaminobiciclicos y sus usos
CR8636A (es) Compuestos utiles para el tratamiento de enfermedades
AR074379A1 (es) Inhibidor de triazolotiadiazola de la proteina quinasa c-met
GT200300241A (es) Benzoxazinonas sustituidas y usos de las mismas
GT200500308A (es) Nonadepsipeptidos acilados ii
CR9623A (es) Anticuerpos humanizados especificos para nogo-a y sus usos farmaceuticos